The US Bankruptcy Court gave an order approving the bidding procedures relating to the sale of substantially all the assets of Impel Pharmaceuticals Inc. on January 11, 2024. The Court approved the asset purchase agreement between the debtor and JN Bidco LLC, the stalking horse bidder, for the sale of substantially all its assets for a purchase price of $17.5 million in cash. To qualify as a qualified bidder, interested parties should submit their bids by January 23, 2024.

The initial minimum overbid should be more than the initial purchase price. If the debtor receives any qualified bids, then it would hold an auction for its assets on January 29, 2024. At the auction, the subsequent bids would be in increments of $0.25 million.

The stalking horse bidder would be entitled to a break-up fee of $0.45 million and expense reimbursement of $0.3 million in case of termination of the asset purchase agreement. The sale hearing is scheduled for February 1, 2024. The sale is expected to close by February 12, 2024.